Thu, 25th Mar 2021 15:46
COPENHAGEN, March 25 (Reuters) - Iceland will resume the use
of AstraZeneca's COVID-19 vaccine after suspending it on March
11 pending investigations into reports that it might be linked
to blood clots in some people who had been vaccinated, the
government said on Thursday.
A number of other European countries have also resumed use
of the vaccine after the European Medicines Agency confirmed
that it was safe to administer.
(Reporting by Jacob Gronholt-Pedersen)
(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...
(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.
(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...
(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...
(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...
Astrazeneca (AZN)